Head-to-head · free
Quanome Technologies, Inc. vs RXO, Inc.
QNME vs RXO — return on capital, cash generation, margins and balance sheet side by side.
QNME
3 / 6
measures where QNME leads
RXO
3 / 6
measures where RXO leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | QNME · FY2026 | RXO · FY2025 |
|---|---|---|
| Revenue | $5.9M | $5.7B |
| Net income | (9.5M) | (100.0M) |
| Revenue growth (yearly, multi-year) | -68.1% | 6.2% |
| Free cash flow | — | (8.0M) |
| Free cash flow margin | — | -0.1% |
| Net cash / (debt) | — | — |
| ROIC | — | — |
| Return on equity | — | -6.3% |
| Gross margin | 56.7% | 14.4% |
| Operating margin | -125.0% | -0.1% |
| Net debt / EBITDA | 0.03x | 10.46x |
Figures are as reported by each company; latest fiscal year shown.
Where Quanome Technologies, Inc.'s cash went (FY2026)
- Capital spending
- $2048
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where RXO, Inc.'s cash went (FY2025)
- Capital spending
- $59.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free